Loading…

Ex-vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti-pig T and B cell immune response

Singh AK, Seavey CN, Horvath KA, Mohiuddin MM. Ex‐vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti‐pig T and B cell immune response. Xenotransplantation 2012; 19: 102–111. © 2012 John Wiley & Sons A/S. : Background:  CD4+ CD25+ FoxP3+ regulatory T (Treg) cells play an important r...

Full description

Saved in:
Bibliographic Details
Published in:Xenotransplantation (Københaven) 2012-03, Vol.19 (2), p.102-111
Main Authors: Singh, Avneesh K., Seavey, Caleb N., Horvath, Keith A., Mohiuddin, Muhammad M.
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 111
container_issue 2
container_start_page 102
container_title Xenotransplantation (Københaven)
container_volume 19
creator Singh, Avneesh K.
Seavey, Caleb N.
Horvath, Keith A.
Mohiuddin, Muhammad M.
description Singh AK, Seavey CN, Horvath KA, Mohiuddin MM. Ex‐vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti‐pig T and B cell immune response. Xenotransplantation 2012; 19: 102–111. © 2012 John Wiley & Sons A/S. : Background:  CD4+ CD25+ FoxP3+ regulatory T (Treg) cells play an important role in regulating immune responses. A very small number of Treg cells are present in peripheral blood and lymphoid organs, but due to their ability to suppress the immune response, they have a high potential for immunotherapy in clinics. Successful ex‐vivo expansion of naturally occurring CD4+ CD25+ T cells has been achieved after TCR stimulation in the presence of T cell growth factors. In this study, we evaluated the role of these Treg cells in suppressing proliferative response of baboon T and B cells to pig xenoantigens. Methods:  Naturally occurring baboon CD4+ CD25+ regulatory T cells (nTreg) were sorted from peripheral blood and expanded in the presence of either anti‐CD3/CD28 beads or irradiated pig peripheral blood mononuclear cells with IL‐2. Treg cells were also enriched directly from CD4+ T cells cultured in the presence of rapamycin (0.1–10 nm). Mixed lymphocyte culture and polyclonal B cell stimulation with ex‐vivo Treg cells were performed to assess the function of ex‐vivo expanded Treg cells. Results:  The nTreg cells were expanded to more than 200‐fold in 4 weeks and retained all the nTreg cell phenotypic characteristics, including high levels of FoxP3 expression. 2‐fold increase in enrichment of CD4+ CD25+ FoxP3+ Treg cells from CD4+ cells was observed with rapamycin compared to cultures without rapamycin. The ex‐vivo expanded Treg cells obtained from both methods were able to suppress the baboon anti‐porcine xenogeneic T and B cell immune response in‐vitro efficiently (more than 90% suppression at 1 : 1 ratio of T regulatory cells: T effector cells), and their suppression potential was retained even at 1 : 256 ratio. However, freshly isolated nTreg cells had only 70% suppression at 1 : 1 ratio, and their suppressive ability was reduced to ≤50% at 1 : 16 ratio. Furthermore, we have found that ex‐vivo expanded Treg can also suppress the proliferation of B cells after polyclonal stimulation. Forty to 50 percent reduction in B cell proliferation was observed when ex‐vivo expanded Treg cells were added to the culture at a 1 : 1 ratio. The addition of CD4+ CD25Neg cells however induced vigorous proliferation. Conclusion:  Ex‐vivo expanded CD4+ CD25+ Fox
doi_str_mv 10.1111/j.1399-3089.2012.00697.x
format article
fullrecord <record><control><sourceid>proquest_wiley</sourceid><recordid>TN_cdi_proquest_miscellaneous_1017959192</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1017959192</sourcerecordid><originalsourceid>FETCH-LOGICAL-i2097-eb0fce2f7fce90f98b006242b44971aa350384fba0ef7c86bce29a3910430f2e3</originalsourceid><addsrcrecordid>eNo9kF1LwzAUhoMoOKf_IZeCtJ4k_Qp4o_sU5kSZuLuQrunI7JfNOrt_b7rpcnFyIM97OHkQwgRcYs_9xiWMc4dBxF0KhLoAAQ_d9gz1Tg_nqAccIicI_OUlujJmAwDMj_weSkats9O7Equ2kkWiEhzLuCwLPBh6d7ZQf6rxolZrvFJZZrBpqqpWxvxjsthqp9JrvLBtgp8OGNZ53hQKW7AqC6Ou0UUqM6Nu_u4--hiPFoOpM3udPA8eZ46mwENHxZCuFE1DWzmkPIrtX6hHY8_jIZGS-cAiL40lqDRcRUFsYS4ZJ-AxSKlifXR7nFvV5XejzFbk2nQLyUKVjREESMh9Tji16MMR_dGZ2ouq1rms95YQnVWxEZ080ckTnVVxsCpasRzNbWPjzjGuzVa1p7isv0QQstAXn_OJoOO3-fvkZSCG7Bcp_nuQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017959192</pqid></control><display><type>article</type><title>Ex-vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti-pig T and B cell immune response</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Singh, Avneesh K. ; Seavey, Caleb N. ; Horvath, Keith A. ; Mohiuddin, Muhammad M.</creator><creatorcontrib>Singh, Avneesh K. ; Seavey, Caleb N. ; Horvath, Keith A. ; Mohiuddin, Muhammad M.</creatorcontrib><description>Singh AK, Seavey CN, Horvath KA, Mohiuddin MM. Ex‐vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti‐pig T and B cell immune response. Xenotransplantation 2012; 19: 102–111. © 2012 John Wiley &amp; Sons A/S. : Background:  CD4+ CD25+ FoxP3+ regulatory T (Treg) cells play an important role in regulating immune responses. A very small number of Treg cells are present in peripheral blood and lymphoid organs, but due to their ability to suppress the immune response, they have a high potential for immunotherapy in clinics. Successful ex‐vivo expansion of naturally occurring CD4+ CD25+ T cells has been achieved after TCR stimulation in the presence of T cell growth factors. In this study, we evaluated the role of these Treg cells in suppressing proliferative response of baboon T and B cells to pig xenoantigens. Methods:  Naturally occurring baboon CD4+ CD25+ regulatory T cells (nTreg) were sorted from peripheral blood and expanded in the presence of either anti‐CD3/CD28 beads or irradiated pig peripheral blood mononuclear cells with IL‐2. Treg cells were also enriched directly from CD4+ T cells cultured in the presence of rapamycin (0.1–10 nm). Mixed lymphocyte culture and polyclonal B cell stimulation with ex‐vivo Treg cells were performed to assess the function of ex‐vivo expanded Treg cells. Results:  The nTreg cells were expanded to more than 200‐fold in 4 weeks and retained all the nTreg cell phenotypic characteristics, including high levels of FoxP3 expression. 2‐fold increase in enrichment of CD4+ CD25+ FoxP3+ Treg cells from CD4+ cells was observed with rapamycin compared to cultures without rapamycin. The ex‐vivo expanded Treg cells obtained from both methods were able to suppress the baboon anti‐porcine xenogeneic T and B cell immune response in‐vitro efficiently (more than 90% suppression at 1 : 1 ratio of T regulatory cells: T effector cells), and their suppression potential was retained even at 1 : 256 ratio. However, freshly isolated nTreg cells had only 70% suppression at 1 : 1 ratio, and their suppressive ability was reduced to ≤50% at 1 : 16 ratio. Furthermore, we have found that ex‐vivo expanded Treg can also suppress the proliferation of B cells after polyclonal stimulation. Forty to 50 percent reduction in B cell proliferation was observed when ex‐vivo expanded Treg cells were added to the culture at a 1 : 1 ratio. The addition of CD4+ CD25Neg cells however induced vigorous proliferation. Conclusion:  Ex‐vivo expanded CD4+ CD25+ FoxP3+ Treg cells can be used to efficiently suppress xenogeneic immune responses by inhibiting T and B cell proliferation. These ex‐vivo expanded Treg cells may also be used with other immunosuppressive agents to overcome xenograft rejection in preclinical xenotransplantation models.</description><identifier>ISSN: 0908-665X</identifier><identifier>EISSN: 1399-3089</identifier><identifier>DOI: 10.1111/j.1399-3089.2012.00697.x</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>CD25 antigen ; CD28 antigen ; CD4 antigen ; Cell culture ; Cell proliferation ; Effector cells ; Foxp3 protein ; Immunoregulation ; Immunosuppressive agents ; Immunotherapy ; Interleukin 2 ; Lymphocytes B ; Lymphocytes T ; Papio ; Peripheral blood mononuclear cells ; Rapamycin ; T regulatory cells ; T-cell receptor ; Treg ; xenoantigens ; xenograft ; Xenografts</subject><ispartof>Xenotransplantation (Københaven), 2012-03, Vol.19 (2), p.102-111</ispartof><rights>2012 John Wiley &amp; Sons A/S</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Singh, Avneesh K.</creatorcontrib><creatorcontrib>Seavey, Caleb N.</creatorcontrib><creatorcontrib>Horvath, Keith A.</creatorcontrib><creatorcontrib>Mohiuddin, Muhammad M.</creatorcontrib><title>Ex-vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti-pig T and B cell immune response</title><title>Xenotransplantation (Københaven)</title><description>Singh AK, Seavey CN, Horvath KA, Mohiuddin MM. Ex‐vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti‐pig T and B cell immune response. Xenotransplantation 2012; 19: 102–111. © 2012 John Wiley &amp; Sons A/S. : Background:  CD4+ CD25+ FoxP3+ regulatory T (Treg) cells play an important role in regulating immune responses. A very small number of Treg cells are present in peripheral blood and lymphoid organs, but due to their ability to suppress the immune response, they have a high potential for immunotherapy in clinics. Successful ex‐vivo expansion of naturally occurring CD4+ CD25+ T cells has been achieved after TCR stimulation in the presence of T cell growth factors. In this study, we evaluated the role of these Treg cells in suppressing proliferative response of baboon T and B cells to pig xenoantigens. Methods:  Naturally occurring baboon CD4+ CD25+ regulatory T cells (nTreg) were sorted from peripheral blood and expanded in the presence of either anti‐CD3/CD28 beads or irradiated pig peripheral blood mononuclear cells with IL‐2. Treg cells were also enriched directly from CD4+ T cells cultured in the presence of rapamycin (0.1–10 nm). Mixed lymphocyte culture and polyclonal B cell stimulation with ex‐vivo Treg cells were performed to assess the function of ex‐vivo expanded Treg cells. Results:  The nTreg cells were expanded to more than 200‐fold in 4 weeks and retained all the nTreg cell phenotypic characteristics, including high levels of FoxP3 expression. 2‐fold increase in enrichment of CD4+ CD25+ FoxP3+ Treg cells from CD4+ cells was observed with rapamycin compared to cultures without rapamycin. The ex‐vivo expanded Treg cells obtained from both methods were able to suppress the baboon anti‐porcine xenogeneic T and B cell immune response in‐vitro efficiently (more than 90% suppression at 1 : 1 ratio of T regulatory cells: T effector cells), and their suppression potential was retained even at 1 : 256 ratio. However, freshly isolated nTreg cells had only 70% suppression at 1 : 1 ratio, and their suppressive ability was reduced to ≤50% at 1 : 16 ratio. Furthermore, we have found that ex‐vivo expanded Treg can also suppress the proliferation of B cells after polyclonal stimulation. Forty to 50 percent reduction in B cell proliferation was observed when ex‐vivo expanded Treg cells were added to the culture at a 1 : 1 ratio. The addition of CD4+ CD25Neg cells however induced vigorous proliferation. Conclusion:  Ex‐vivo expanded CD4+ CD25+ FoxP3+ Treg cells can be used to efficiently suppress xenogeneic immune responses by inhibiting T and B cell proliferation. These ex‐vivo expanded Treg cells may also be used with other immunosuppressive agents to overcome xenograft rejection in preclinical xenotransplantation models.</description><subject>CD25 antigen</subject><subject>CD28 antigen</subject><subject>CD4 antigen</subject><subject>Cell culture</subject><subject>Cell proliferation</subject><subject>Effector cells</subject><subject>Foxp3 protein</subject><subject>Immunoregulation</subject><subject>Immunosuppressive agents</subject><subject>Immunotherapy</subject><subject>Interleukin 2</subject><subject>Lymphocytes B</subject><subject>Lymphocytes T</subject><subject>Papio</subject><subject>Peripheral blood mononuclear cells</subject><subject>Rapamycin</subject><subject>T regulatory cells</subject><subject>T-cell receptor</subject><subject>Treg</subject><subject>xenoantigens</subject><subject>xenograft</subject><subject>Xenografts</subject><issn>0908-665X</issn><issn>1399-3089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNo9kF1LwzAUhoMoOKf_IZeCtJ4k_Qp4o_sU5kSZuLuQrunI7JfNOrt_b7rpcnFyIM97OHkQwgRcYs_9xiWMc4dBxF0KhLoAAQ_d9gz1Tg_nqAccIicI_OUlujJmAwDMj_weSkats9O7Equ2kkWiEhzLuCwLPBh6d7ZQf6rxolZrvFJZZrBpqqpWxvxjsthqp9JrvLBtgp8OGNZ53hQKW7AqC6Ou0UUqM6Nu_u4--hiPFoOpM3udPA8eZ46mwENHxZCuFE1DWzmkPIrtX6hHY8_jIZGS-cAiL40lqDRcRUFsYS4ZJ-AxSKlifXR7nFvV5XejzFbk2nQLyUKVjREESMh9Tji16MMR_dGZ2ouq1rms95YQnVWxEZ080ckTnVVxsCpasRzNbWPjzjGuzVa1p7isv0QQstAXn_OJoOO3-fvkZSCG7Bcp_nuQ</recordid><startdate>201203</startdate><enddate>201203</enddate><creator>Singh, Avneesh K.</creator><creator>Seavey, Caleb N.</creator><creator>Horvath, Keith A.</creator><creator>Mohiuddin, Muhammad M.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>201203</creationdate><title>Ex-vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti-pig T and B cell immune response</title><author>Singh, Avneesh K. ; Seavey, Caleb N. ; Horvath, Keith A. ; Mohiuddin, Muhammad M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i2097-eb0fce2f7fce90f98b006242b44971aa350384fba0ef7c86bce29a3910430f2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CD25 antigen</topic><topic>CD28 antigen</topic><topic>CD4 antigen</topic><topic>Cell culture</topic><topic>Cell proliferation</topic><topic>Effector cells</topic><topic>Foxp3 protein</topic><topic>Immunoregulation</topic><topic>Immunosuppressive agents</topic><topic>Immunotherapy</topic><topic>Interleukin 2</topic><topic>Lymphocytes B</topic><topic>Lymphocytes T</topic><topic>Papio</topic><topic>Peripheral blood mononuclear cells</topic><topic>Rapamycin</topic><topic>T regulatory cells</topic><topic>T-cell receptor</topic><topic>Treg</topic><topic>xenoantigens</topic><topic>xenograft</topic><topic>Xenografts</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Singh, Avneesh K.</creatorcontrib><creatorcontrib>Seavey, Caleb N.</creatorcontrib><creatorcontrib>Horvath, Keith A.</creatorcontrib><creatorcontrib>Mohiuddin, Muhammad M.</creatorcontrib><collection>Istex</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Xenotransplantation (Københaven)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Singh, Avneesh K.</au><au>Seavey, Caleb N.</au><au>Horvath, Keith A.</au><au>Mohiuddin, Muhammad M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ex-vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti-pig T and B cell immune response</atitle><jtitle>Xenotransplantation (Københaven)</jtitle><date>2012-03</date><risdate>2012</risdate><volume>19</volume><issue>2</issue><spage>102</spage><epage>111</epage><pages>102-111</pages><issn>0908-665X</issn><eissn>1399-3089</eissn><abstract>Singh AK, Seavey CN, Horvath KA, Mohiuddin MM. Ex‐vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti‐pig T and B cell immune response. Xenotransplantation 2012; 19: 102–111. © 2012 John Wiley &amp; Sons A/S. : Background:  CD4+ CD25+ FoxP3+ regulatory T (Treg) cells play an important role in regulating immune responses. A very small number of Treg cells are present in peripheral blood and lymphoid organs, but due to their ability to suppress the immune response, they have a high potential for immunotherapy in clinics. Successful ex‐vivo expansion of naturally occurring CD4+ CD25+ T cells has been achieved after TCR stimulation in the presence of T cell growth factors. In this study, we evaluated the role of these Treg cells in suppressing proliferative response of baboon T and B cells to pig xenoantigens. Methods:  Naturally occurring baboon CD4+ CD25+ regulatory T cells (nTreg) were sorted from peripheral blood and expanded in the presence of either anti‐CD3/CD28 beads or irradiated pig peripheral blood mononuclear cells with IL‐2. Treg cells were also enriched directly from CD4+ T cells cultured in the presence of rapamycin (0.1–10 nm). Mixed lymphocyte culture and polyclonal B cell stimulation with ex‐vivo Treg cells were performed to assess the function of ex‐vivo expanded Treg cells. Results:  The nTreg cells were expanded to more than 200‐fold in 4 weeks and retained all the nTreg cell phenotypic characteristics, including high levels of FoxP3 expression. 2‐fold increase in enrichment of CD4+ CD25+ FoxP3+ Treg cells from CD4+ cells was observed with rapamycin compared to cultures without rapamycin. The ex‐vivo expanded Treg cells obtained from both methods were able to suppress the baboon anti‐porcine xenogeneic T and B cell immune response in‐vitro efficiently (more than 90% suppression at 1 : 1 ratio of T regulatory cells: T effector cells), and their suppression potential was retained even at 1 : 256 ratio. However, freshly isolated nTreg cells had only 70% suppression at 1 : 1 ratio, and their suppressive ability was reduced to ≤50% at 1 : 16 ratio. Furthermore, we have found that ex‐vivo expanded Treg can also suppress the proliferation of B cells after polyclonal stimulation. Forty to 50 percent reduction in B cell proliferation was observed when ex‐vivo expanded Treg cells were added to the culture at a 1 : 1 ratio. The addition of CD4+ CD25Neg cells however induced vigorous proliferation. Conclusion:  Ex‐vivo expanded CD4+ CD25+ FoxP3+ Treg cells can be used to efficiently suppress xenogeneic immune responses by inhibiting T and B cell proliferation. These ex‐vivo expanded Treg cells may also be used with other immunosuppressive agents to overcome xenograft rejection in preclinical xenotransplantation models.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><doi>10.1111/j.1399-3089.2012.00697.x</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0908-665X
ispartof Xenotransplantation (Københaven), 2012-03, Vol.19 (2), p.102-111
issn 0908-665X
1399-3089
language eng
recordid cdi_proquest_miscellaneous_1017959192
source Wiley-Blackwell Read & Publish Collection
subjects CD25 antigen
CD28 antigen
CD4 antigen
Cell culture
Cell proliferation
Effector cells
Foxp3 protein
Immunoregulation
Immunosuppressive agents
Immunotherapy
Interleukin 2
Lymphocytes B
Lymphocytes T
Papio
Peripheral blood mononuclear cells
Rapamycin
T regulatory cells
T-cell receptor
Treg
xenoantigens
xenograft
Xenografts
title Ex-vivo expanded baboon CD4+ CD25Hi Treg cells suppress baboon anti-pig T and B cell immune response
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A15%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ex-vivo%20expanded%20baboon%20CD4+%20CD25Hi%20Treg%20cells%20suppress%20baboon%20anti-pig%20T%20and%20B%20cell%20immune%20response&rft.jtitle=Xenotransplantation%20(K%C3%B8benhaven)&rft.au=Singh,%20Avneesh%20K.&rft.date=2012-03&rft.volume=19&rft.issue=2&rft.spage=102&rft.epage=111&rft.pages=102-111&rft.issn=0908-665X&rft.eissn=1399-3089&rft_id=info:doi/10.1111/j.1399-3089.2012.00697.x&rft_dat=%3Cproquest_wiley%3E1017959192%3C/proquest_wiley%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i2097-eb0fce2f7fce90f98b006242b44971aa350384fba0ef7c86bce29a3910430f2e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1017959192&rft_id=info:pmid/&rfr_iscdi=true